--- title: "KO (Trans): Volume up 5% with faster momentum; FY guidance raised" type: "Topics" locale: "en" url: "https://longbridge.com/en/dolphin/post/44572080.md" description: "Q3 unit case volume rose 5%, with organic revenue up 7%. Guidance was raised to at least +5% organic revenue for the full year, comparable EPS of at least +11%, and FCF of at least $13bn.Price/mix was only +1%, while Q4 has six fewer days and slight destocking, and the company is advancing CCBA refranchising while evaluating an IPO of its India bottling business." datetime: "2026-10-27T14:04:58.000Z" locales: - [en](https://longbridge.com/en/dolphin/post/44572080.md) - [zh-CN](https://longbridge.com/zh-CN/dolphin/post/44572080.md) - [zh-HK](https://longbridge.com/zh-HK/dolphin/post/44572080.md) author: "[Dolphin Research](https://longbridge.com/en/dolphin.md)" generator: "portal-rs" --- # KO (Trans): Volume up 5% with faster momentum; FY guidance raised **Dolphin Research summary of** $Coca Cola(KO.US) **Q3 2026 earnings call transcript** **I. Core takeaways from the print** 1\. **Shareholder returns and balance sheet** a. Free cash flow reached $11.4bn for the first three quarters, up YoY. Net debt/EBITDA is 1.3x, below the 2–2.5x target range. b. The balance sheet is being managed prudently while awaiting a court ruling in the IRS litigation. Capital priorities are unchanged: invest in the biz. and return cash to shareholders, with dividends the primary tool for now. 2\. **FY2026 guidance** a. Organic revenue to grow at least 5%, embedding a slight Q4 destock and the impact of six fewer days. Comparable FX-neutral EPS growth, ex-M&A and divestitures, of at least 9%. b. Divestitures to reduce comparable net revenue by about 2% and comparable EPS by about 1%. This assumes the sale of CCBA closes in Q4, pending regulatory approval. c. FX to contribute approx. +1ppt to comparable net revenue and approx. +3ppts to comparable EPS. The base effective tax rate is 19.7%, including a non-sustainable one-off benefit. d. Comparable EPS to increase at least 11% vs. $3.00 in 2025. Free cash flow of at least $13.0bn. 3\. **Q4 and 2027 considerations** a. Q4: six fewer days YoY and a modest destock are expected. Full-year concentrate shipments to be slightly below unit cases, while CCBA refranchising to drag comparable net revenue by 4ppts and comparable EPS by 3ppts, with a modest positive margin impact. b. 2027: CCBA to reduce comparable net revenue by 8ppts and comparable EPS by 2ppts, but to benefit margins and returns. At current FX and hedges, revenue and EPS face slight FX headwinds, and formal guidance will be provided in Feb. c. An IPO of the India bottling business is under evaluation. Commodities are broadly manageable, but logistics are lifting overall cost pressure. 4\. **Key metrics this quarter** a. Topline: organic revenue +7%, unit cases +5%, and concentrate shipments led unit cases by 2ppts on timing. Comparable EPS was $0.91 (+11%), including a 2ppt FX tailwind. b. Price/mix +1%: list pricing added +4ppts. This was partially offset by region mix, timing of inputs, and category mix totaling -3ppts. c. Margins: comparable GPM expanded by about 170bps and comparable OPM by about 110bps. This reflected underlying improvement, FX tailwinds, and structural effects from last year's sale of the Nigeria finished goods biz. **II. Details from the call** **2.1 Management commentary highlights** 1\. **Overall view** a. Geopolitical conflicts and cost pressures are accelerating and affecting many consumers. The company has 32 billion-dollar brands and has strengthened consumer recruitment, digital, RGM, and system execution in recent years. b. Three common themes from market visits: affordability strategies are working, zero-sugar and classic are bringing in new users, and execution and localization are helping win share. 2\. **North America** a. Revenue grew and value share rose. Unit cases were flat due to July 4 timing and temporary issues in some finished goods, but trends improved sequentially through the quarter. b. The Coca-Cola Trademark, Fairlife, Powerade, Fresca, and smartwater saw strong volume gains. Mr. Pibb delivered another double-digit increase. c. Marketing: continued the 'Fan Work Is Thirsty Work' campaign for football season. Fanta launched Halloween limited flavors and collectible packs, Fairlife Nutrition Plan vanilla returned, and BODYARMOR FIT Zero Sugar with caffeine and electrolytes was introduced. 3\. **Latin America** a. Several key markets were pressured early in the year, but Q3 accelerated materially with targeted actions. Unit cases grew and value share increased, with broad-based improvement. b. Mexico remains challenging but is making progress via affordability, RGM, and local marketing. Brazil shows strong momentum across categories, with the Coca-Cola Trademark, Sprite, and sports drinks performing well, while Argentina remains difficult. 4\. **EMEA** a. Europe: unit cases grew, but value share declined in several key Western European markets, and actions are underway. A 500ml 'super can' and price-pack architecture are being used to recruit consumers. b. Africa: achieved high single-digit growth on a tough base and gained share. South Africa introduced India's affordable single-serve format, locally named 'Mashesha' (meaning 'fast'). c. Eurasia and Middle East: geopolitical conflicts continue to disrupt some areas, yet volumes and share still increased. Local flavors such as Sprite Mint Cool and Fanta Pomegranate were launched. 5\. **Asia Pacific** a. Share, unit cases, revenue, and profit all grew. However, region mix and affordability actions pressured price/mix. b. India delivered strong volume, with all top-10 brands up double digits. Sprite tied meals with QSRs, lifting Sprite volumes in the region by nearly 20%. c. China remains a soft consumption environment but still delivered robust volume growth. The Coca-Cola Trademark and Fanta led gains, and digital commerce and emerging channels grew sharply. d. Japan saw volume declines due to macro and severe weather, but share increased and zero-sugar accelerated. Thailand launched Coca-Cola Zero Zero, and affordable single-serve packs in Vietnam now cover over 400,000 outlets with high repeat rates. **2.2 Q&A** **Q: What did you learn from the World Cup and the US 250th anniversary summer activations, and how will you retain the incremental demand?** A: **The two events tested end-to-end activation, and the related technologies and data are being reused in Q4 and 2027.** Brand strategy, innovation, RGM, and execution were advanced in an integrated way, with strong system performance in North America and globally. Technologies, data, and AI used during the World Cup were applied to Fanta Halloween's connected packaging, taking consumers from content to transaction. The company has now delivered 22 consecutive quarters of global value share gains. **Q: Can the system sustain volume growth in 2027 given a high unit case base?** A: **Management acknowledged the high base but provided no quantified target and expressed confidence in the long-term growth algorithm.** This year's high growth was 'earned' by staying close to consumers and keeping plans flexible, and bottlers and customers have responded positively to next year's plans. **Q: Price/mix is around 2% this year, likely a decade low. What is the 2027 strategy, and how much is under your control?** A: **The company remains committed to balancing 2–3ppts from both volume and price/mix, and about two-thirds of adverse mix is manageable.** The two-year unit case CAGR is about 2% and may be slightly higher after the past two quarters, while base pricing was +4ppts this quarter and YTD, with slightly higher inflation in some EMs. The drag is mainly on mix, roughly two-thirds from deliberate actions or structural changes tied to this year's finished goods. Excluding Topo Chico supply issues and timing of inputs, full-year price/mix is broadly within the target range. In 2027, EM volume will still outpace DMs, so region mix headwinds will persist, and pricing will reflect inflation, consumer health by market, competition, and customer context, with details in Feb. **Q: With mix under pressure, what drove a 70bp improvement in base GPM?** A: **Base GPM improvement reflects revenue quality and cost control, and the long-term algorithm implies mild, sustainable expansion.** Management decomposes GPM into base, structural, and FX effects, and FX is a tailwind this year. **Q: SG&A stepped up again this quarter. How much did marketing rise, and is this to set up 2027?** A: **Spending was pulled forward to set up a strong start to 2027, with online advertising up double digits.** Multiple initiatives are being advanced with bottlers, and no overall marketing growth rate was disclosed. Looking ahead, marketing is expected to grow roughly in line with GP to shape the P&L toward the target profile. **Q: Inflation pressures fall more on bottlers. How do you view bottler economics and implications for 2027 pricing and investment?** A: **No direct commentary on bottler profitability, noting costs remain volatile but manageable.** Market-level brand plans are set from a system view, and, as in prior years, investments were pulled forward this year. Commodities are manageable at present. A cross-enterprise procurement group is coordinating sourcing for next year's key inputs, and productivity and RGM tools are being used to align the operating environment with growth plans, with updates to come in the months ahead. **Q: Why was North America unit cases flat, will it improve, and how do Topo Chico and Fairlife high bases affect price/mix?** A: **Excluding July 4 timing and high bases in premium finished goods, North America unit cases were actually up.** Revenue grew, share increased, and margins expanded in North America, with pricing aligned to inflation. Price/mix was pressured by last year's strong base in premium finished brands such as Topo Chico and BODYARMOR. The Coca-Cola Trademark resumed growth, Coke Zero grew double digits, and Fairlife and Powerade increased, while Sprite, BODYARMOR, and the supply chain need improvements. The CFO added that restaurants remain under pressure and scanner data show at-home consumption stronger than away-from-home given consumer stress. This pressure is expected to persist through year-end and into 2027. **Q: Under affordability strategies, can bottlers both hold entry price points and selectively raise prices?** A: **Affordability and premiumization run in parallel and are embedded in RGM.** Value resonates across markets and consumer groups, and if a pack has a strong value proposition and relevance, its distribution is expanded, otherwise plans are adjusted. For example, India’s affordable single-serve PET using plasma tech was introduced in Africa, enabling longer routes while preserving shelf life. Premiumization is driven by category mix, with Core Power and smartwater in North America and different pack sizes in other markets. **Q: With six fewer days and destock in Q4, how big is the revenue drag in percentage points?** A: **No quantification was provided, and management said 2026 is the toughest year to align unit cases and shipments.** Q1 had six extra days and Q4 has six fewer, and the external environment is hard to predict, so the system prefers to stay ahead. Some segments plan to destock after their YTD performance, and year-end cutoffs are hard to pin precisely. Guidance reflects the best information today, and updates will be provided before year-end if needed. **Q: What drove the FCF raise, what does 'flexibility' in 2027 mean, and how does it relate to the IRS case?** A: **Cash flow reflects operations, working capital, and capex timing, and flexibility is to prepare for the IRS ruling.** Cash conversion is at the best level in years, and capex has been slower YTD and will catch up in Q4. The IRS ruling is expected in the coming months, and the company is prepared for both best- and worst-case outcomes, with the balance sheet in its best shape in years. Near term, focus is on organic investments, while remaining open to other opportunities, and returns to shareholders are primarily via dividends for now. **Q: Will North America's sequential improvement carry into Q4, and how are at-home vs. away-from-home trends evolving?** A: **Run-rate trends remain positive, but Q4 faces the largest quarterly base in North America and six fewer days.** July started behind due to holiday timing and then improved sequentially, and last year's high base in Topo Chico also matters. Topo Chico has returned to the Texas market as a first step, and volumes will gradually recover through 2027. Mr. Pibb is outperforming but from a small base, and there was no further elaboration on at-home vs. away-from-home splits. **Q: Does the 2027 FX outlook reflect the sharp moves in the last day or two?** A: **No, it does not reflect the past 24–48 hours, especially the Brazilian real.** Management will monitor closely and update if moves remain material over the coming weeks. **Q: Are full-year concentrate shipments above or below unit cases, and where is destock concentrated?** A: **The base assumption is full-year shipments are slightly below unit cases, and no specific regions were named.** This assumption is tied to guidance, but 2026 is unusual and outcomes may deviate. **Q: With shipments running well ahead of unit cases, how does the margin look once the two realign, given the GP and SG&A leverage this creates?** A: **Margins are expected to expand for the full year, in line with YTD trends.** No separate attribution of leverage effects was provided. **Q: What is the plan for Fairlife, what defines success, what are the usage occasions, and what about international opportunities?** A: **Fairlife is growing double digits across the portfolio, and the priority is to keep up with demand, while international opportunities are not being discussed yet.** Fairlife, Nutrition Plan, and Core Power all grew double digits, and early in the year supply lagged due to the Webster plant ramp, which has improved and enabled the vanilla launch. Banana flavor is slated for the 2027 pipeline. Markets outside the US and Canada remain under study and will be incorporated into the long-term plan. \ **Risk disclosure and statements:**[**Dolphin Research disclaimer and general disclosures**](https://support.longbridge.global/topics/misc/dolphin-disclaimer) ### Related Stocks - [KO.US](https://longbridge.com/en/quote/KO.US.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**